Krishna Vaddi - 31 Dec 2024 SCHEDULE 13G/A Report for Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)

Filing Manager: Krishna Vaddi
Reporting Manager: Vaddi Krishna
Security: Prelude Therapeutics Inc Common Stock, par value $0.0001 per share
Symbol: PRLD
Shares outstanding: 57,780,316 shares
Disclosed Ownership: 5,489,130 shares
Ownership: 9.5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:19:58 UTC
Date of event: 31 Dec 2024
Next filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vaddi Krishna	9.5%	5,489,130	5,489,130	0	/s/ Krishna Vaddi	Krishna Vaddi